Cadrenal Therapeutics, Inc. Common Stock ( CVKD) - Key Metrics
CVKD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.14 | -$0.77 | -$0.77 |
| 2026Q1 | $0 | -$1.04 | -$1.25 | -$1.25 |
| 2025Q4 | $0 | -$1.52 | -$1.29 | -$1.29 |
| 2025Q3 | $0 | -$1.31 | -$1.15 | -$1.15 |
| 2025Q2 | $0 | -$1.87 | -$1.54 | -$1.54 |
CVKD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.73 |
| 2026Q1 | 0% | -1.23 |
| 2025Q4 | 0% | -1.20 |
| 2025Q3 | 0% | -2.64 |
| 2025Q2 | 0% | -1.61 |
CVKD
Price: $1.58
52 week price:
Earnings Per Share: -4.88 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 5.8 million